106 related articles for article (PubMed ID: 11220683)
1. High-dose corticosteroid administration induces increase of serum macrophage migration inhibitory factor in patients with Vogt-Koyanagi-Harada's disease.
Kitaichi N; Kotake S; Mizue Y; Sasamoto Y; Goda C; Iwabuchi K; Onoé K; Matsuda H; Nishihira J
Microbiol Immunol; 2000; 44(12):1075-7. PubMed ID: 11220683
[TBL] [Abstract][Full Text] [Related]
2. Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis.
Kitaichi N; Kotake S; Sasamoto Y; Namba K; Matsuda A; Ogasawara K; Onoé K; Matsuda H; Nishihira J
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):247-50. PubMed ID: 9888451
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Vogt-Koyanagi- Harada's disease during pregnancy.
Miyata N; Sugita M; Nakamura S; Isobe K; Matoba H; Tsuda K; Tanaka K; Ohno S
Jpn J Ophthalmol; 2001; 45(2):177-80. PubMed ID: 11313051
[TBL] [Abstract][Full Text] [Related]
4. Correlation between peripapillary atrophy and corticosteroid therapy in patients with Vogt-Koyanagi-Harada disease.
Jap A; Luu CD; Yeo I; Chee SP
Eye (Lond); 2008 Feb; 22(2):240-5. PubMed ID: 16980924
[TBL] [Abstract][Full Text] [Related]
5. Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease.
Lai TY; Chan RP; Chan CK; Lam DS
Eye (Lond); 2009 Mar; 23(3):543-8. PubMed ID: 18369377
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with cyclosporin A and steroid in severe case of Vogt-Koyanagi-Harada's disease.
Wakatsuki Y; Kogure M; Takahashi Y; Oguro Y
Jpn J Ophthalmol; 1988; 32(3):358-60. PubMed ID: 3230722
[TBL] [Abstract][Full Text] [Related]
7. Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease.
Sasamoto Y; Ohno S; Matsuda H
Ophthalmologica; 1990; 201(3):162-7. PubMed ID: 2089358
[TBL] [Abstract][Full Text] [Related]
8. Adalimumab Treatment in Patients with Vogt-Koyanagi-Harada Disease.
Couto C; Schlaen A; Frick M; Khoury M; Lopez M; Hurtado E; Goldstein D
Ocul Immunol Inflamm; 2018; 26(3):485-489. PubMed ID: 27775450
[TBL] [Abstract][Full Text] [Related]
9. Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with Behçet's disease and Vogt-Koyanagi-Harada's disease.
Uchio E; Matsumoto T; Tanaka SI; Ohno S
Clin Exp Rheumatol; 1999; 17(2):179-84. PubMed ID: 10342043
[TBL] [Abstract][Full Text] [Related]
10. [Vogt-Koyanagi-Harada syndrome].
Babushkin AE; Siuniaeva SI; Fattakhov BT; Vavilova OV
Vestn Oftalmol; 2003; 119(2):43-5. PubMed ID: 13678012
[No Abstract] [Full Text] [Related]
11. Vogt-Koyanagi-Harada disease in monozygotic twins.
Itho S; Kurimoto S; Kouno T
Int Ophthalmol; 1992 Jan; 16(1):49-54. PubMed ID: 1537650
[TBL] [Abstract][Full Text] [Related]
12. Vogt-Koyanagi-Harada's disease presenting polymorphonuclear pleocytosis in the cerebrospinal fluid at the early active stage.
Kato Y; Kurimura M; Yahata Y; Tajima K; Kato T
Intern Med; 2006; 45(12):779-81. PubMed ID: 16847368
[TBL] [Abstract][Full Text] [Related]
13. [Vogt-Koyanagi-Harada's disease: 3 cases].
Mikou O; Chiheb S; Zouhair K; Jarmouni RI; Nejjam F; El Ouazzani T; Amraoui A; Lakhdar H
Ann Dermatol Venereol; 2000 Mar; 127(3):282-4. PubMed ID: 10804302
[TBL] [Abstract][Full Text] [Related]
14. Correlation between sunset glow fundus and initial dosage of corticosteroid in patients with Vogt-Koyanagi-Harada disease.
Guo YL; Du Y; He JF
Am J Ophthalmol; 2009 May; 147(5):946; author reply 946-7. PubMed ID: 19376333
[No Abstract] [Full Text] [Related]
15. Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome.
Agarwal M; Ganesh SK; Biswas J
Ocul Immunol Inflamm; 2006 Dec; 14(6):333-9. PubMed ID: 17162603
[TBL] [Abstract][Full Text] [Related]
16. Vogt-Koyanagi-Harada syndrome in two patients with immunoglobulin A nephropathy.
Matsuo T; Masuda I; Ota K; Yamadori I; Sunami R; Nose S
Acta Med Okayama; 2007 Oct; 61(5):305-9. PubMed ID: 17971847
[TBL] [Abstract][Full Text] [Related]
17. Vogt-Koyanagi-Harada's syndrome associated with Hashimoto's thyroiditis.
Chi HI; Furue M; Ishibashi Y
J Dermatol; 1994 Sep; 21(9):683-6. PubMed ID: 7962975
[TBL] [Abstract][Full Text] [Related]
18. [Vogt-Koyanagi-Harada syndrome and cortisone].
Lugossy G
Bull Mem Soc Fr Ophtalmol; 1976; (87):44-6. PubMed ID: 1268419
[No Abstract] [Full Text] [Related]
19. Management of pediatric Vogt-Koyanagi- Harada (VKH)-associated panuveitis.
Soheilian M; Aletaha M; Yazdani S; Dehghan MH; Peyman GA
Ocul Immunol Inflamm; 2006 Apr; 14(2):91-8. PubMed ID: 16597538
[TBL] [Abstract][Full Text] [Related]
20. Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease.
Hirose S; Saito W; Yoshida K; Saito M; Dong Z; Namba K; Satoh H; Ohno S
Acta Ophthalmol; 2008 Dec; 86(8):902-7. PubMed ID: 19016661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
